In our recent studies on the role of neutral sphingomyelinase 2 (nSMase2) in obesity-associated NAFLD, we observed that the onset of the steatosis was associated with the accumulation of nSMase2 on the surface of the LD [40] (submitted). This evidence concerns the gene SMPD3 and metabolic dysfunction-associated steatotic liver disease.